Mankind Pharma has reported its results for the first quarter ended June 30, 2026 (Q1FY27).
The company has reported a 34.49% rise in its net profit at Rs 558.49 crore for the quarter ended June 30, 2026, as compared to Rs 415.27 crore for the same quarter in the previous year. Total income increased by 13.78% to Rs 2,998.01 crore for Q1FY27 as compared to Rs 2,634.94 crore for the corresponding quarter of the previous year.
On a consolidated basis, the company has reported a 29.60% rise in its net profit at Rs 568.06 crore for Q1FY27, as compared to Rs 438.32 crore for the same quarter in the previous year. Total income increased by 11.65% to Rs 4,075.59 crore for Q1FY27 as compared to Rs 3,650.23 crore for the corresponding quarter of the previous year.
